Veterinary Medicine Information website

Letifend (--) - Lyophilisate and solvent for solution for injection

Authorised
  • Leishmania infantum, zymodeme MON-1, recombinant protein Q

Product identification

Medicine name:
Letifend (--) - Lyophilisate and solvent for solution for injection
Active substance:
  • Leishmania infantum, zymodeme MON-1, recombinant protein Q
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leishmania infantum, zymodeme MON-1, recombinant protein Q
    Presentation_strength:≥36.7 ELISA Units Reference:In house Index:0
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AO01
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Austria
  • Cyprus
  • France
  • Germany
  • Greece
  • Italy
  • Malta
  • Portugal
  • Spain
Package description:
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 20 vials; solvent: 20 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 10 vials; solvent: 10 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 1 vial; solvent: 1 vial, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 50 vials; solvent: 50 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 100 vials; solvent: 100 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 5 vials; solvent: 5 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 4 vials; solvent: 4 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml
  • Packaging:Lyophilisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 25 vials; solvent: 25 vials, Content:Lyophilisate: 1 dose; solvent: 0.8 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • LETI Pharma, S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • LETI Pharma, S.L.U.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 6/11/2024
Download
Croatian (PDF)
Published on: 6/11/2024
Estonian (PDF)
Published on: 6/11/2024
Greek (PDF)
Published on: 6/11/2024
French (PDF)
Published on: 6/11/2024
Hungarian (PDF)
Published on: 6/11/2024
Lithuanian (PDF)
Published on: 6/11/2024
Latvian (PDF)
Published on: 6/11/2024
Finnish (PDF)
Published on: 6/11/2024
Icelandic (PDF)
Published on: 6/11/2024
Italian (PDF)
Published on: 6/11/2024
Spanish (PDF)
Published on: 6/11/2024
Bulgarian (PDF)
Published on: 6/11/2024
German (PDF)
Published on: 6/11/2024
Danish (PDF)
Published on: 6/11/2024
Czech (PDF)
Published on: 6/11/2024
Maltese (PDF)
Published on: 6/11/2024
Norwegian (PDF)
Published on: 6/11/2024
Dutch (PDF)
Published on: 6/11/2024
Polish (PDF)
Published on: 6/11/2024
Portuguese (PDF)
Published on: 6/11/2024
Swedish (PDF)
Published on: 6/11/2024
Slovenian (PDF)
Published on: 6/11/2024
Romanian (PDF)
Published on: 6/11/2024
Slovak (PDF)
Published on: 6/11/2024

ema-puar-letifend-v-3865-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download